Immune Resilience and Personalized Nutrition: Jeffrey Bland on Healthy Aging Today and Tomorrow

At the 45th Natural Products Expo West, Jeffrey Bland, PhD, founder of Big Bold Health and a pioneer in functional medicine, reflected on more than four decades of progress in the natural products industry and where it’s headed next.

A trained nutritional biochemist, Bland has long advocated for elevating the role of nutrition science in standard medical practice. He believes the industry is entering a pivotal phase defined by clinical validation, measurable outcomes, and personalized health strategies.

Over his 30-year career, Bland has contributed to hundreds of clinical studies and helped develop numerous products grounded in measurable outcomes. Key to this process, he noted, is identifying meaningful biomarkers that can demonstrate how nutritional interventions impact the body.

That scientific focus will culminate in an 850-person, double-blind, placebo-controlled trial investigating the effects of Tartary buckwheat sprouts on immune aging and longevity, Bland said. Expected to conclude in mid-2026, the study aims to provide robust human data on how targeted nutrition can influence immune resilience, an area Bland believes is central to reducing chronic disease risk and supporting healthy aging.

Looking ahead, Bland believes the industry must move beyond unsupported claims toward demonstrable clinical value. For Big Bold Health, that means continuing to invest in rigorous research and applying those findings to both product development and consumer education.

Subscribe to our weekly newsletter to stay current with all our content.